A retrospective database analysis of insulin use patterns in insulin-na&iuml;ve patients with type 2 diabetes initiating basal insulin or mixtures

A retrospective database analysis of insulin use patterns in insulin-na&iuml;ve patients with type 2 diabetes initiating basal insulin or mixtures

Machaon MK Bonafede1, Anupama Kalsekar2, Manjiri Pawaskar2, Kimberly M Ruiz3, Amelito M Torres3, Karen R Kelly2, Suellen M Curkendall31Thomson Reuters Inc, Cambridge, Massachusetts, USA; 2Eli Lilly and Company, Indianapolis, Indiana, USA; 3Thomson Reuters Inc, Washington, DC, USAObjective: To descri...

Full description

Bibliographic Details
Main Authors:	Machaon MK Bonafede, Anupama Kalsekar, Manjiri Pawaskar, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-06-01
Series:	Patient Preference and Adherence
Online Access:	http://www.dovepress.com/a-retrospective-database-analysis-of-insulin-use-patterns-in-insulin-n-a4661

Similar Items

Insulin use and persistence in patients with type 2 diabetes adding mealtime insulin to a basal regimen: a retrospective database analysis
by: Torres Amelito M, et al.
Published: (2011-01-01)

Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens
by: Gogas Yavuz D, et al.
Published: (2015-08-01)

Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Naïve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia
by: Shafie AA, et al.
Published: (2020-06-01)

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
by: Sami N. Nasrallah, et al.
Published: (2012-04-01)

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
by: Sami N. Nasrallah, et al.
Published: (2012-01-01)

Concentrated insulins: the new basal insulins
by: Lamos EM, et al.
Published: (2016-03-01)

Degludec insulin: A novel basal insulin
by: Sanjay Kalra, et al.
Published: (2011-01-01)

Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
by: Ivan Ivanovich Dedov, et al.
Published: (2014-12-01)

Future of newer basal insulin
by: S V Madhu, et al.
Published: (2013-01-01)

Cardiovascular effects of basal insulins
by: Mannucci E, et al.
Published: (2015-07-01)

Efficacy and Safety of Insulin Degludec/Insulin Aspart Compared with a Conventional Premixed Insulin or Basal Insulin: A Meta-Analysis
by: Shinje Moon, et al.
Published: (2021-09-01)

Insulin degludec: overview of a novel ultra long-acting basal insulin.
by: Gough, S, et al.
Published: (2013)

Insulin degludec: Overview of a novel ultra long-acting basal insulin
by: Gough, S, et al.
Published: (2013)

Lixisenatide as add-on therapy to basal insulin
by: Brown DX, et al.
Published: (2013-12-01)

Comparison between basal insulin glargine and NPH insulin in patients with diabetes type 1 on conventional intensive insulin therapy
by: Pešić Milica, et al.
Published: (2007-01-01)

Comparison of Insulin Detemir and Insulin Glargine for Hospitalized Patients on a Basal-Bolus Protocol
by: Sondra Davis, et al.
Published: (2017-04-01)

The effects of protease inhibitors on basal and insulin-stimulated lipid metabolism, insulin binding, and signaling
by: Catarina Cammalleri, et al.
Published: (2003-01-01)

Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
by: Rodrigo Oliveira Moreira, et al.
Published: (2018-04-01)

Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations.
by: Turner, R, et al.
Published: (1979)

Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
by: Dippel, Franz-Werner, et al.
Published: (2010-01-01)

Basal insulin therapy in type 2 diabetes.
by: Bethel, M, et al.
Published: (2005)

HORMONE SIGNALING - BASAL INSULIN-SECRETION AND ACUTE INSULIN-RESPONSE IN NORMAL AND GLUCOSE INTOLERANT MAN
by: Rice, H, et al.
Published: (1993)

Insulin degludec as an ultralong-acting basal insulin once a day: a systematic review
by: Wang F, et al.
Published: (2012-07-01)

79. Basal-bolus insulin compared to premixed insulin in cardiac outpatients with type 2 diabetes
by: A. Enoz
Published: (2016-07-01)

Insulin degludec: A novel ultra-acting basal insulin: Potential usefulness in hospitalized patients
by: Sukhminder Jit Singh Bajwa, et al.
Published: (2015-01-01)

Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment
by: Kai‐Jen Tien, et al.
Published: (2019-05-01)

Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes
by: Han Na Jang, et al.
Published: (2019-12-01)

Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
by: Kostev K, et al.
Published: (2015-01-01)

A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements.
by: Phillips, M, et al.
Published: (1979)

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
by: Elena V. Buryukova, et al.
Published: (2017-12-01)

Effect of the Concomitant Use of Subcutaneous Basal Insulin and Intravenous Insulin Infusion in the Treatment of Severe Hyperglycemic Patients
by: Yejee Lim, et al.
Published: (2022-06-01)

Basal Insulin Initiation and Maintenance in Adults with Type 2 Diabetes Mellitus in the United States
by: Kalirai S, et al.
Published: (2020-04-01)

A practical guide to basal and prandial insulin therapy.
by: Holman, R, et al.
Published: (1985)

Pulsatile, synchronous basal insulin and glucagon secretion in man.
by: Lang, D, et al.
Published: (1982)

Molecular engineering of safe and efficacious oral basal insulin
by: Frantisek Hubálek, et al.
Published: (2020-07-01)

The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state.
by: Matthews, DR, et al.
Published: (1997)

The effect of insulin on equine lamellar basal epithelial cells mediated by the insulin-like growth factor-1 receptor
by: Courtnay L. Baskerville, et al.
Published: (2018-11-01)

The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes
by: Ravi Retnakaran, et al.
Published: (2023-03-01)

Insulin for the non-insulin dependent?
by: Holman, R
Published: (1988)

Predictors of Glycemic Response and Change in HbA1c Following Newly Initiated Basal Insulin Among Insulin Naïve Adults With Type 2 Diabetes
by: Mojtaba Malek, et al.
Published: (2017-10-01)